[EN] COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE<br/>[FR] COMPOSÉS ET MÉTHODE DE BLOCAGE DE LA TRANSMISSION D'UN PARASITE DU PALUDISME
申请人:US HEALTH
公开号:WO2018071836A1
公开(公告)日:2018-04-19
Disclosed are compounds of formula (I) and formula (II): (I) (II) wherein R1, R2, A, and B are as defined herein. Also disclosed is a method of blocking transmission of a Plasmodium parasite and a method of treating or preventing malaria comprising administering to an animal an effective amount of a first compound of formula (I) or (II) either alone or in combination with a second compound selected from elesclomol, NSC174938, NVP-AUY922, Maduramicin, Narasin, Alvespimycin, Omacetaxine, Thiram, Zinc pyrithione, Phanquinone, Bortezomib, Salinomycin sodium, Monensin sodium, Dipyrithione, Dicyclopentamethylene-thiuram disulfide, YM155, Withaferin A, Adriamycin, Romidepsin, AZD-1152-HQPA, CAY10581, Plicamycin, CUDC-101, Auranofin, Trametinib, GSK-458, Afatinib, and Panobinostat.
本公开了化合物的结构式(I)和结构式(II)如下:(I)(II)其中R1、R2、A和B的定义如本文所述。还公开了一种阻断疟原虫传播的方法以及一种治疗或预防疟疾的方法,包括向动物施用结构式(I)或(II)的第一化合物的有效量,可以单独使用或与从Elesclomol、NSC174938、NVP-AUY922、Maduramicin、Narasin、Alvespimycin、Omacetaxine、Thiram、Zinc pyrithione、Phanquinone、Bortezomib、Salinomycin sodium、Monensin sodium、Dipyrithione、Dicyclopentamethylene-thiuram disulfide、YM155、Withaferin A、Adriamycin、Romidepsin、AZD-1152-HQPA、CAY10581、Plicamycin、CUDC-101、Auranofin、Trametinib、GSK-458、Afatinib和Panobinostat中选择的第二化合物结合使用。